Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|7|8|1034-1047

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.7, Iss.8, 2015-08, pp. : 1034-1047

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Circulating tumor DNA in early‐stage breast cancer: personalized biomarkers for occult metastatic disease and risk of relapse?

By  

EMBO Molecular Medicine, Vol. 7, Iss. 8, 2015-08 ,pp. : 994-995

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of circulating tumor cells using oHSV1‐hTERT‐GFP in lung cancer

By  

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 44-50

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection and analysis of circulating large intergenic non‐coding RNA regulator of reprogramming in plasma for breast cancer

By  

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 66-74

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patients' preferences for post‐treatment breast cancer follow‐up in primary care vs. secondary care: a qualitative study

By  

Health Expectations (Electronic), Vol. 18, Iss. 6, 2015-12 ,pp. : 2192-2201

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of DNA damage in peripheral blood mononuclear cells from pancreatic cancer patients

By  

Molecular Carcinogenesis, Vol. 899-1987, Iss. 10, 2015-10 ,pp. : 1220-1226

John Wiley & Sons Inc

Access to resources Recommend Favorite